248 related articles for article (PubMed ID: 29444744)
1. Overexpression of Pyruvate Dehydrogenase E1α Subunit Inhibits Warburg Effect and Induces Cell Apoptosis Through Mitochondria-Mediated Pathway in Hepatocellular Carcinoma.
Sun J; Li J; Guo Z; Sun L; Juan C; Zhou Y; Gu H; Yu Y; Hu Q; Kan Q; Yu Z
Oncol Res; 2019 Mar; 27(4):407-414. PubMed ID: 29444744
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers.
Zhong Y; Li X; Ji Y; Li X; Li Y; Yu D; Yuan Y; Liu J; Li H; Zhang M; Ji Z; Fan D; Wen J; Goscinski MA; Yuan L; Hao B; Nesland JM; Suo Z
Oncotarget; 2017 Feb; 8(8):13344-13356. PubMed ID: 28076853
[TBL] [Abstract][Full Text] [Related]
3. AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.
Glushakova LG; Lisankie MJ; Eruslanov EB; Ojano-Dirain C; Zolotukhin I; Liu C; Srivastava A; Stacpoole PW
Mol Genet Metab; 2009 Nov; 98(3):289-99. PubMed ID: 19586787
[TBL] [Abstract][Full Text] [Related]
4. Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity.
Kwak CH; Jin L; Han JH; Han CW; Kim E; Cho M; Chung TW; Bae SJ; Jang SB; Ha KT
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825675
[TBL] [Abstract][Full Text] [Related]
5. Insulin induces phosphorylation of pyruvate dehydrogenase through RhoA activation pathway in HepG2 cells.
Islam R; Kim JG; Park Y; Cho JY; Cap KC; Kho AR; Chung WS; Suh SW; Park JB
FASEB J; 2019 Feb; 33(2):2072-2083. PubMed ID: 30226812
[TBL] [Abstract][Full Text] [Related]
6. SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis.
Xu L; Li Y; Zhou L; Dorfman RG; Liu L; Cai R; Jiang C; Tang D; Wang Y; Zou X; Wang L; Zhang M
Cancer Med; 2019 May; 8(5):2380-2391. PubMed ID: 30993888
[TBL] [Abstract][Full Text] [Related]
7. SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells.
Ozden O; Park SH; Wagner BA; Song HY; Zhu Y; Vassilopoulos A; Jung B; Buettner GR; Gius D
Free Radic Biol Med; 2014 Nov; 76():163-172. PubMed ID: 25152236
[TBL] [Abstract][Full Text] [Related]
8. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
[TBL] [Abstract][Full Text] [Related]
10. miR‑21‑5p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer.
Liu Z; Yu M; Fei B; Fang X; Ma T; Wang D
Oncol Rep; 2018 Nov; 40(5):2955-2963. PubMed ID: 30226598
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
12. Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effect.
Fan J; Kang HB; Shan C; Elf S; Lin R; Xie J; Gu TL; Aguiar M; Lonning S; Chung TW; Arellano M; Khoury HJ; Shin DM; Khuri FR; Boggon TJ; Kang S; Chen J
J Biol Chem; 2014 Sep; 289(38):26533-26541. PubMed ID: 25104357
[TBL] [Abstract][Full Text] [Related]
13. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
[TBL] [Abstract][Full Text] [Related]
14. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
16. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
17. Determination of Pyruvate Metabolic Fates Modulates Head and Neck Tumorigenesis.
Chen TY; Hsieh YT; Huang JM; Liu CJ; Chuang LT; Huang PC; Kuo TY; Chia HY; Chou CY; Chang CW; Chen YF; Chen HM; Lo JF; Li WC
Neoplasia; 2019 Jul; 21(7):641-652. PubMed ID: 31100640
[TBL] [Abstract][Full Text] [Related]
18. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.
Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J
Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405
[TBL] [Abstract][Full Text] [Related]
19. Hexokinase II promotes the Warburg effect by phosphorylating alpha subunit of pyruvate dehydrogenase.
Luo F; Li Y; Yuan F; Zuo J
Chin J Cancer Res; 2019 Jun; 31(3):521-532. PubMed ID: 31354221
[TBL] [Abstract][Full Text] [Related]
20. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
